Quest Diagnostics Pre-Tax Profit Margin 2010-2024 | DGX

Current and historical pre-tax profit margin for Quest Diagnostics (DGX) from 2010 to 2024. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue. Quest Diagnostics pre-tax profit margin for the three months ending March 31, 2024 was .
Quest Diagnostics Pre-Tax Profit Margin Historical Data
Date TTM Revenue TTM Pre-Tax Income Pre-Tax Margin
2024-03-31 $9.29B $1.12B 12.05%
2023-12-31 $9.25B $1.13B 12.21%
2023-09-30 $9.30B $1.00B 10.78%
2023-06-30 $9.49B $1.05B 11.11%
2023-03-31 $9.60B $1.06B 11.04%
2022-12-31 $9.88B $1.24B 12.50%
2022-09-30 $10.29B $1.63B 15.82%
2022-06-30 $10.58B $1.93B 18.25%
2022-03-31 $10.68B $2.43B 22.71%
2021-12-31 $10.79B $2.60B 24.09%
2021-09-30 $11.05B $2.86B 25.85%
2021-06-30 $11.06B $2.95B 26.71%
2021-03-31 $10.34B $2.39B 23.14%
2020-12-31 $9.44B $1.88B 19.96%
2020-09-30 $8.36B $1.45B 17.39%
2020-06-30 $7.53B $0.97B 12.89%
2020-03-31 $7.66B $0.98B 12.81%
2019-12-31 $7.73B $1.08B 13.93%
2019-09-30 $7.64B $0.92B 11.98%
2019-06-30 $7.57B $0.91B 12.03%
2019-03-31 $7.54B $0.91B 12.07%
2018-12-31 $7.53B $0.93B 12.30%
2018-09-30 $7.56B $0.99B 13.14%
2018-06-30 $7.52B $0.99B 13.09%
2018-03-31 $7.47B $1.01B 13.56%
2017-12-31 $7.40B $1.03B 13.92%
2017-09-30 $7.10B $1.04B 14.63%
2017-06-30 $7.13B $1.07B 15.00%
2017-03-31 $7.17B $1.16B 16.18%
2016-12-31 $7.21B $1.09B 15.05%
2016-09-30 $7.50B $1.05B 13.99%
2016-06-30 $7.50B $1.35B 18.04%
2016-03-31 $7.52B $1.17B 15.56%
2015-12-31 $7.49B $1.10B 14.72%
2015-09-30 $7.53B $1.10B 14.63%
2015-06-30 $7.55B $0.72B 9.57%
2015-03-31 $7.53B $0.75B 9.99%
2014-12-31 $7.44B $0.82B 11.07%
2014-09-30 $7.31B $0.83B 11.40%
2014-06-30 $7.19B $1.28B 17.74%
2014-03-31 $7.11B $1.30B 18.34%
2013-12-31 $7.15B $1.32B 18.53%
2013-09-30 $7.16B $1.34B 18.72%
2013-06-30 $7.20B $0.96B 13.27%
2013-03-31 $7.26B $1.00B 13.73%
2012-12-31 $7.38B $1.07B 14.47%
2012-09-30 $7.37B $1.12B 15.22%
2012-06-30 $7.45B $1.13B 15.21%
2012-03-31 $7.48B $1.11B 14.90%
2011-12-31 $7.39B $0.85B 11.49%
2011-09-30 $7.35B $0.82B 11.19%
2011-06-30 $7.31B $0.85B 11.64%
2011-03-31 $7.28B $0.90B 12.40%
2010-12-31 $7.26B $1.18B 16.20%
2010-09-30 $7.39B $1.21B 16.36%
2010-06-30 $7.43B $1.23B 16.50%
2010-03-31 $7.45B $1.22B 16.33%
2009-12-31 $7.46B $1.23B 16.47%
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $15.695B $9.252B
Quest Diagnostics, Inc. is the provider of commercial laboratory services. Quest provides lab testing services to physicians, hospitals, managed care organizations, employers, government institutions and other clinical laboratories. The company consists of 2 business groups - Diagnostic Information Services and Diagnostic Solutions. The company's focus is on two elements - to accelerate growth and to drive operational excellence. Restore Growth: The company has adopted seven tactical approaches to accelerate growth such as sales and marketing; development of esoteric testing through a disease focus; partnerships with hospitals and successful testing of international IDNs; creation of value from information assets; leadership in companion diagnostics; extension into adjacent markets. Drive Operational excellence: The company plans to focus on four strategic requirements - to enhance end-to-end customer value chain, enterprise information technology architecture, business performance tools and cost excellence.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $17.537B 10.61
DaVita (DVA) United States $12.150B 15.09
Encompass Health (EHC) United States $8.507B 21.78
Chemed (CHE) United States $8.408B 26.06
Elanco Animal Health (ELAN) United States $8.297B 21.53
Option Care Health (OPCH) United States $5.048B 19.11
RadNet (RDNT) United States $4.325B 90.06
Amedisys (AMED) United States $3.145B 22.28
Astrana Health (ASTH) United States $2.239B 30.28
LifeStance Health (LFST) United States $2.179B 0.00
Addus HomeCare (ADUS) United States $1.827B 26.14
U.S Physical Therapy (USPH) United States $1.534B 41.06
Pennant (PNTG) United States $0.706B 37.29
Aveanna Healthcare Holdings (AVAH) United States $0.539B 0.00
Atai Life Sciences (ATAI) Germany $0.270B 0.00
Daxor (DXR) United States $0.045B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.026B 0.00
ATI Physical Therapy (ATIP) United States $0.021B 0.00
Psychemedics (PMD) United States $0.015B 0.00
Ontrak (OTRK) United States $0.013B 0.00
Novo Integrated Sciences (NVOS) United States $0.010B 0.00
IMAC Holdings (BACK) United States $0.004B 0.00